Low LATS2 expression was significantly related to tumor differentiation (P = 0.002), TNM stage (P = 0.002), primary tumor (T; P = 0.041), lymph node metastases (N; P = 0.012), and distant metastases (M; P = 0.006). Here, LATS2 is linked to neoplasm.